"We have seen positive signs in the PI-88 Phase I single agent trial where over 40% of the melanoma patients showed tumor growth retarded for periods lasting up to 30 months
and from the Phase II multiple myeloma trial where 39% of patients have shown cancer stabilization for periods up to 2 years".
Comment: These are highly significant results. And as far as I know the first meaningful result of any Melanoma cancer trial.
Melanoma is a most dreaded disease and treatment agents fear to tread in this field.
Phase I was very succesfull and if Phase II is, then there is a possibility that some concessions can be obtained from the FDA.
And what about selling this drug if proven successful?
At this stage, there would be a big demand for it IMHO.
Gerry Readers, please do your own research and you decide if and when to buy, hold or sell any stocks.
PGL Price at posting:
0.0¢ Sentiment: None Disclosure: Held